Studies of linear ubiquitin and different modes of cell death induction by TNFfamily members in aetiology and treatment of auto-immunity (360G-Wellcome-096831_Z_11_A)

£2,654,537

I. What are the inducers, mechanisms and immunological consequences of proinflammatorycell death when ubiquitin-signalling is perturbed and how can they beinhibited?II. Can type-II auto-immunity be treated by preventing pro- inflammatory cell death and/orits immunological consequences?III. Can we identify auto-immune patients who may benefit from a therapy that preventsnecroptosis and/or its pro-inflammatory consequences?

Where is this data from?

This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.

Grant Details

Region London
Award Date 2011-10-04T00:00:00+00:00
Internal ID 096831/Z/11/A
Planned Dates: End Date 2018-12-31T00:00:00+00:00
Planned Dates: Start Date 2013-01-01T00:00:00+00:00
Amount Awarded 2654537
Financial Year 2011/12
Lead Applicant Prof Henning Walczak
Grant Programme: Title Investigator Award in Science
Applicant Surname Walczak
Approval Committee Science Interview Panel
Recipient Org: Country United Kingdom
Recipient Org: City London
Has the grant transferred? No
Research conducted at multiple locations? No
Total amount including partnership funding 2654537